Building a modern data network to advane knowledge. At ATHN, we partner with the blood disorders community, government, and industry by providing technology to manage data, support research, measure outcomes—and ultimately improve care.

Our Top Stories


Feature1 athntranscends sm
  • ATHN Transcends
    ATHN Transcends is a natural history cohort study focused on participants with congenital or acquired non-neoplastic blood disorders and connective tissue disorders with bleeding tendencies. ATHN Transcends provides clinical researchers with a uniform, secure, unbiased, and enduring method to collect long-term safety and efficacy data to increase knowledge in these important areas of research.
  • Electronic Informed Consent (eIC) and ATHN 9
    ATHN’s new eConsent portal will facilitate and streamline the informed consent process for patients in ATHN studies. The eConsent portal is currently only available for participants enrolling in ATHN 9.

National Projects

Hp2030 badge
  • Healthy People 2030 Champion
    ATHN is proud to have been recognized as a Healthy People 2030 Champion by the U.S. Department of Health and Human Services’ Office of Disease Prevention and Health Promotion. This distinction is awarded to organizations that have demonstrated interest and commitment to disease prevention and health promotion, as well as having an organizational mission that is aligned with the HP2030 program vision of “a society in which all people can achieve their full potential for health and well-being across the lifespan.”
  • ATHN Data Quality Counts
    This competitive award is supported by The Hemophilia Alliance, The Alliance Pharmacy, and Indiana Hemophilia & Thrombosis Center and provides funding to enrich the ATHNdataset.
  • Promo robusthealth v2
  • Office of Public Health Initiatives
    The ATHN Office of Public Health Initiatives (OPHI) aims to leverage ATHN’s capabilities to support medically underserved populations by strengthening our partnerships throughout the blood disorders community. We’re working to establish a Health Equity Program, expand ATHN’s focus on sickle cell disease, and more.

Upcoming Events

DEC, 2022
ASH – American Society of Hematology
New Orleans, LA
FEB, 2023
European Association for Haemophilia and Allied Disorders (EAHAD)
Manchester, England
MAR, 2023
19th Annual 340B Coalition Winter Conference
San Diego, CA

Featured Publications

Therapeutic and technological advancements in haemophilia care: Quantum leaps forward published in Haemophilia, February 2022. Download full article
Health insurance coverage and switching among people with hemophilia A in the United States published in Journal of Managed Care + Specialty Pharmacy, November 2021. Read the full article
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects ( <12 years) with haemophilia A or B with inhibitors published in Haemophilia, July 2022. Read the full article